Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment
Rebecca Rosberg, Karolina I. Smolag, Jonas Sjölund, Elinn Johansson, Christina Bergelin, Julia Wahldén, Vasiliki Pantazopoulou, Crister Ceberg, Kristian Pietras, Anna M. Blom, Alexander Pietras
Rebecca Rosberg, Karolina I. Smolag, Jonas Sjölund, Elinn Johansson, Christina Bergelin, Julia Wahldén, Vasiliki Pantazopoulou, Crister Ceberg, Kristian Pietras, Anna M. Blom, Alexander Pietras
View: Text | PDF
Research Article Oncology

Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment

  • Text
  • PDF
Abstract

Glioblastoma (GBM) is the most aggressive form of glioma with a high rate of relapse despite intensive treatment. Tumor recurrence is tightly linked to radio-resistance, which in turn is associated with hypoxia. Here, we discovered a strong link between hypoxia and local complement signaling using publicly available bulk, single-cell, and spatially resolved transcriptomic data from patients with GBM. Complement component 3 (C3) and the receptor C3AR1 were both associated with aggressive disease and shorter survival in human glioma. In a genetically engineered mouse model of GBM, we found C3 specifically in hypoxic tumor areas. In vitro, we found an oxygen level–dependent increase in C3 and C3AR1 expression in response to hypoxia in several GBM and stromal cell types. C3a induced M2 polarization of cultured microglia and macrophages in a C3aR-dependent fashion. Targeting C3aR using the antagonist SB290157 prolonged survival of glioma-bearing mice both alone and in combination with radiotherapy while reducing the number of M2-polarized macrophages. Our findings establish a strong link between hypoxia and complement pathways in GBM and support a role of hypoxia-induced C3a/C3aR signaling as a contributor to glioma aggressiveness by regulating macrophage polarization.

Authors

Rebecca Rosberg, Karolina I. Smolag, Jonas Sjölund, Elinn Johansson, Christina Bergelin, Julia Wahldén, Vasiliki Pantazopoulou, Crister Ceberg, Kristian Pietras, Anna M. Blom, Alexander Pietras

×

Figure 5

C3a promotes M2 polarization of microglia and macrophages.

Options: View larger image (or click on image) Download as PowerPoint
C3a promotes M2 polarization of microglia and macrophages.
(A and B) Flo...
(A and B) Flow cytometry for indicated markers of M2 polarization in HMC3 microglia cells treated as indicated with SB290157 (SB), DMSO, and C3a (n = 4). (C) Proliferation of HMC3 cells treated or not with SB290157 as measured by the WST-1 assay (n = 3). (D–F) Flow cytometry for indicated markers of M2 (CD206, CD163) and M1 (CD86) polarization in primary murine macrophages treated as indicated with SB290157 (SB), DMSO, and C3a (n = 3). (G) Representative image of immunofluorescence staining of CD31 and CD206 in murine gliomas induced through RCAS-PDGFB and RCAS-shp53 in Nestin/tv-a mice. Scale bars: 100 μm, 50 μm (insets). (H) Representative image of immunofluorescence staining of C3 and F4/80 in murine gliomas induced through RCAS-PDGFB and RCAS-shp53 in Nestin/tv-a mice. Scale bars: 50 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts